Effice

Name

Effice

Legal name

EFFICE SERVICIOS PARA LA INVESTIGACION S.L.

Website

https://efficecro.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH)

Keywords

• Clinical research services
• Contract research organization
• Clinical trial management
• Biostatistics services
• Pharmacovigilance services

Headquarters

HQ city

Madrid

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Research Services: Professional services revenue model providing comprehensive CRO services to pharmaceutical, biotechnology, and medical device companies. Services are offered as full project engagements or individual task-specific services including study design, project management, monitoring (on-site and remote), statistical analysis, data management, pharmacovigilance, and regulatory support. Revenue is generated through project-based contracts with pharmaceutical companies, biotech firms, medical device companies, academic institutions, and independent researchers.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Effice is a Spain-based Contract Research Organization (CRO) providing end-to-end clinical research services to pharmaceutical, biotechnology, medical device, and academic clients. Core offerings include clinical trial design, project management, monitoring (on-site and remote), biostatistics, pharmacovigilance, data management, and an in-house eClinical technology platform with EDC, CTMS, RTSM, eTMF, and eConsent modules.

Product overview

Effice is a Contract Research Organization (CRO) founded in 2004, headquartered in Spain with global reach. The company offers a comprehensive portfolio of clinical research services centered around its core CRO services, complemented by the eClinical Technology Suite (including EDC, CTMS, RTSM, eTMF, ePRO/eCOA, eConsent, and Medical Devices modules), an open-source eCRD platform, Biostatistics and Data Management services, Monitoring services, and E-learning/training programs. The portfolio serves pharmaceutical, biotechnology, and medical device companies, as well as academic institutions and independent researchers conducting clinical trials and observational studies.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Research Services (CRO) Full-service Contract Research Organization offering clinical trial monitoring, project management, pharmacovigilance, and regulatory affairs for pharmaceutical, biotechnology, and medical device companies, as well as academic and independent researchers. Services cover phases I through IV and post-authorization studies.
• eClinical Technology Suite Comprehensive technology platform for clinical trial management including Visualization, EDC, ePRO/eCOA, CTMS, RTSM, eTMF, and eConsent modules designed to support study progress tracking, patient data collection, and regulatory compliance.
• eCRD (Electronic Case Report Form) Open-source electronic data capture system providing configurable eCRF functionality with secure web access, role-based permissions, monitoring modules, randomization, query management, electronic signatures, and data export capabilities. Validated per GCP and 21 CFR Part 11 requirements.
• Biostatistics Services Statistical services including protocol development, sample size calculation, Statistical Analysis Plan (SAP) creation, patient randomization lists, SAS programming, Clinical Study Report (CSR) generation following ICH/CONSORT/STROBE guidelines, and statistical support for scientific publications including peer review.
• Data Management Services Comprehensive data management including protocol consulting, Case Report Form design, database creation and validation, data entry and review, completeness reports, query management through platform, medical coding, adverse event reconciliation, database closure and quality control, and final dataset generation in multiple formats.
• E-Learning Services Online training programs for pharmaceutical industry professionals, doctors, and researchers including university masters, monographic courses, clinical cases, GCP certification, and statistical training courses available in tailored formats for different profiles and difficulty levels.
• Monitoring Services Clinical monitoring services delivered in-person and remotely according to ICH GCP standards, including site selection, feasibility studies, audits, site initiation visits, monitoring visits, close-out visits, remote site management, TMF management, and investigational product management.

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Partnerships

One partnership is on record.

• Mundo CooperanteminorOthersEffice has collaborated with NGO Mundo Cooperante for over 15 years as part of its commitment to equality and social justice. The current project is a healthcare program for children affected by malaria in Sierra Leone. This partnership reflects the company's CSR values rather than a commercial relationship.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• ICON plc: One of the world's largest CROs with comprehensive clinical, biometrics, laboratory and consulting services — competes for the same pharma/biotech clients as Effice but serves as a broad incumbent with global reach rather than a niche specialist.
• Medpace: Large publicly-traded global CRO offering full-service clinical development across all major therapeutic areas — a scaled competitor that overlaps with Effice's service portfolio but at much broader geographic and operational scale.
• Labcorp Drug Development (formerly Covance): One of the largest global CROs with full-service clinical, central laboratory, and regulatory capabilities — a broad incumbent whose Phase I-IV offerings overlap with Effice's core CRO services.
• SGS Health & Nutrition / SGS Life Sciences: Global life sciences services provider with a clinical research division offering Phase I-IV trials, biometrics and regulatory services across Europe — a broader incumbent competing for similar European CRO contracts.

Direct peers

• PSI CRO AG: Switzerland-headquartered full-service CRO with strong European footprint, providing clinical monitoring, data management, biostatistics and regulatory services to pharma and biotech — a directly comparable mid-sized European CRO competitor.
• Worldwide Clinical Trials: Mid-sized global CRO providing Phase I-IV clinical trial services, biometrics, and pharmacovigilance to pharma/biotech — closely aligned with Effice's full-service model but operating at materially greater scale across multiple continents.
• TFS HealthScience: Global mid-sized CRO headquartered in Sweden with deep European operations, offering full-service clinical trial management, biometrics, and pharmacovigilance — directly comparable to Effice in service mix and target customer base, though at larger scale.
• CTI Clinical Trial & Consulting Services: Mid-sized global CRO with strong European presence, providing full-service clinical research, biometrics and regulatory support across multiple therapeutic areas — directly comparable in service breadth and mid-market positioning.
• Pharm-Olam International: Mid-sized multinational CRO offering full-service clinical development, biometrics and pharmacovigilance with strong EU operations — competes for similar mid-cap pharma and biotech clients and offers comparable therapeutic-area breadth.

Regional players

• Pivotal (Pivotal EU): Spanish-headquartered CRO providing clinical trial services, biometrics, and regulatory affairs to pharma and biotech across Europe — a regionally focused peer that competes with Effice directly within the Iberian market.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInes.linkedin.com/company/effice

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Effice